About BLUEWILLOW BIOLOGICS INC
BlueWillow Biologics is a biotechnology company developing intranasal vaccines using its NanoVax® platform, which has shown promising results in clinical trials for infectious diseases and pandemic preparedness.
Intranasal vaccine developmentNanoVax® adjuvant and antigen delivery platformClinical-stage vaccine technologiesCompatibility with viral, bacterial, and food antigens
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAP | Department of Health and Human Services | $3.3M |
Is this your company?
Claim BLUEWILLOW BIOLOGICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim BLUEWILLOW BIOLOGICS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.